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Matthias H. Tschöp 3,4, Christopher L. Karp 1,2,*ABSTRACTAlterations in the gut microbiota have been proposed to modify the development and maintenance of obesity and its sequelae. Definition of
underlying mechanisms has lagged, although the ability of commensal gut microbes to drive pathways involved in inflammation and metabolism has
generated compelling, testable hypotheses. We studied C57BL/6 mice from two vendors that differ in their obesogenic response and in their
colonization by specific members of the gut microbiota having well-described roles in regulating gut immune responses. We confirmed the presence
of robust differences in weight gain in mice from these different vendors during high fat diet stress. However, neither specific, highly divergent
members of the gut microbiota (Lactobacillus murinus, segmented filamentous bacteria) nor the horizontally transmissible gut microbiota were found
to be responsible. Constitutive differences in locomotor activity were observed, however. These data underscore the importance of selecting
appropriate controls in this widely used model of human obesity.
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Obesity has become a full-fledged pandemic [1]. Increases in obesity
prevalence are expected to drive attendant increases in morbidity and
mortality, as obesity is associated with diverse pernicious sequelae,
including insulin resistance, type 2 diabetes, hypertension, metabolic
syndrome, atherosclerotic coronary artery disease, non-alcoholic fatty
liver disease and various cancers [2–5]. In light of the increasing clinical
and public health burden and the limitations of current therapies, novel
therapeutic approaches to obesity are clearly needed [6,7]. For this,
clearer definition of the cellular and molecular mechanisms causing
obesity, and the relative contribution of such mechanisms to the recent
rapid increase in obesity prevalence will likely be important.
The intestinal microbiota has been proposed to be a contributory factor
in the development and maintenance of obesity [8]. The observations
that gnotobiotic mice are resistant to diet-induced obesity (DIO) and
that transfer of gut bacteria from obese to lean mice can transfer
obesity phenotypes led to studies employing high-throughput genome
sequencing technologies that have reported differences in the guthttp://dx.doi.org/10.1016/j.molmet.2013.04.004
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[9–15]. If the gut microbiome does play a causal role in obesity, there
is promise for approaches (pre-, pro- and anti-biotic) aimed at
modulating the microbiota as novel therapeutic modalities for obesity
and its sequelae. The field remains controversial, however (reviewed in
[8]). Specifically, efforts to replicate the initial description of phylum-
level shifts in the obese human microbiome have only been marginally
successful [8]; it is presently unclear whether this is due to true lack of
association or lack of power to detect associations of the expected
effect size. Additionally, the protection of gnotobiotic mice from DIO,
may depend on mouse strain and obesogenic diet [8]. More generally,
efforts to rigorously define the mechanisms through which putatively
obesogenic microbes might drive obesity phenotypes have been
hampered by a failure to identify specific causal microbes or microbial
properties [8,10,16–21].
Following on the relatively recent understanding that obesity is
associated with a state of chronic, low-grade inflammation [22,23],
the innate immune response to gut microbes has been implicated in the
development of obesity and its pernicious sequelae [16–18,24]. In turn,nnati 45229, OH, USA 2The University of Cincinnati College of Medicine, Cincinnati 45229, OH, USA
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Original articlethe immune system's apparent causal contributions to the development
of obesity appear to be mediated by alterations in the constitution of the
intestinal microbiota. In particular, deletion of genes encoding pattern-
recognition receptors that signal the presence of microbe-associated
molecular patterns, such as Tlr5 and Pycard, has been shown to select
for microbiota that can transfer obesity to other mice [16,17]. Given the
relationship between the intestinal immune system and the gut
microbiota [25,26], we hypothesized that members of the gut microbiota
capable of robust stimulatory effects on the intestinal immune system
might also causally contribute to the development and maintenance of
obesity. This hypothesis was bolstered by the observation that
colonization with one such microbe, segmented filamentous bacteria
(SFB), specifically induced the intestinal expression of genes with dual
roles in both immunity and metabolism, such as Retnlb, Saa1 and Il17a
[25], and altered extraintestinal (patho)physiology in diverse disease
models [27–29].
We thus defined the contribution of the microbiota to obesity in mice
known to differ in both the development of DIO [25,30–33] and in
colonization with particular species known to alter immune responses
[25,34,35]. Specifically, C57BL/6 mice from two commercial vendors,
Jackson Labs and Taconic Farms, are known to vary in their
colonization with SFB and L. murinus, as well as in their body weight
gain in response to high fat diet (HFD) challenge. We confirmed
previously reported differences between these strains in their response
to HFD challenge. However, our data indicate that these differences
are not due to SFB or L. murinus, or, indeed, to the entire gut
microbiota—as assessed by a variety of experimental designs,
including cross-colonization via co-housing, oral gavage of whole
gut microbiota, and oral gavage with specific members of the gut
microbiota. While our data demonstrate that the gut microbiota is not
responsible for the divergent response to HFD challenge in these mice,
we observed constitutively increased locomotor activity in the (leaner)
C57BL/6 mice from Jackson Labs. Moreover, in the course of these
studies, a number of novel experimental techniques were developed to
interrogate the microbiota and their role in modulating host (patho)
physiology.2. MATERIALS AND METHODS
2.1. Mice
Wild type C57BL/6J (NntB6J) and C57BL/6NJ (NntWT) mice were
obtained from Jackson labs. Wild type C57BL/6NTac (NntWT) mice
were obtained from Taconic Farms. Gnotobiotic C57BL/6 germ-free
mice were obtained from the National Gnotobiotic Rodent Resource
Center at UNC-Chapel Hill. Except where otherwise indicated, the
mice from Taconic farms were of the “Murine Pathogen Free™”
(MPF) health status. All mice were housed in a specific pathogen-
free animal facility and handled in high-efficiency particulate-filtered
laminar flow hoods with ad libitum access to food and water at
CCHMC, except for the experiments in the PhenoMaster/LabMaster
cages from TSE Systems, which were performed at the metabolic
diseases institute at the University of Cincinnati. For all experiments,
animal care was performed according to the procedures outlined in
the Guide for Care and Use of Laboratory Animals. All animal studies
were carried out with the approval of the Institutional Animal Care
and Use Committees at which they were performed: the Cincinnati
Children's Hospital Medical Center IACUC (Protocol #1DO5047) and
the University of Cincinnati College of Medicine IACUC (Protocol #06-
08-07-01).172 MOLECULAR METABOL2.2. Fecal and intestinal DNA extraction, 16S rDNA qPCR, cDNA
synthesis, qPCR
DNA extraction was carried out according to a modified version of a
published protocol [36]. Briefly, fecal pellets or approximately 1 cm
sections of terminal ileum were placed in lysis buffer and homogenized
with a TissueLyser (Qiagen) set at 30 Hz for 5 min. For fecal pellets,
0.1 mm zirconia–silica beads (BioSpec, Bartlesville, OK) were used to
homogenize bacterial cells. For homogenization of terminal ilea, such
beads were used in combination with 1/8'' diameter stainless steel
beads (McMaster-Carr). Following extraction and resuspension in DEPC-
treated H2O, DNA quantification was performed with a NanoDrop ND-
1000. 50 ng of DNA was used as the amplification template in a Light
Cycler 480 II using Sybr Green I Master mix (both from Roche).
The following primers for the 16S rDNA of SFB, Lactobacillus murinus, all
Lactobacillus species or all Eubacterial (EUB) species were used: SFB 5′
GACGCTGAGGCATGAGAGCAT, 3′ GACGGCACGGATTGTTATTCA; L. murinus
5′ GCAATGATGCGTAGCCGAAC, 3′ GCACTTTCTTCTCTAACAACAGGG; All
Lactobacillus sp. 5′ AGCAGTAGGGAATCTTCCA, 3′ CACCGCTACACATGGAG;
EUB 5′ ACTCCTACGGGAGGCAGCAGT, 3′ ATTACCGCGGCTGCTGGC [37,38].
Phylum and species levels were then normalized to the total amount of
Eubacterial DNA or, where indicated, total amount of Lactobacillus DNA.
Notably, while the primers used to detect L. murinus were designed to
detect the ASF361 isolate of L. murinus present in altered Schaedler flora,
they have also been predicted to bind the 16S sequence from the closely
related Lactobacillus species, L. animalis [37].
For RNA isolation, tissue samples were homogenized as above in TRIzol
(Invitrogen) with 1/8'' diameter stainless steel beads (McMaster-Carr) to
disrupt the tissue. RNA was extracted according to manufacturer
instructions. Equal amounts of RNA were used as templates to
synthesize cDNA with oligo-dT, random hexamers and Superscript II
reverse transcriptase (Invitrogen). The cDNA was then RNase-digested,
diluted 1:7 in DEPC-treated water and subjected to qPCR analysis using
Light Cycler 480 II (Roche). Sybr Green I Master mix (Roche) and the
following primer pairs [25,39] were used: Gapdh 5′ CCTCGTCCCGTA-
GACAAAATG, 3′ TCTCCACTTTGCCACTGCAA; Saa1 5′ CATTTGTTCAC-
GAGGCTTTCC, 3′ GTTTTTCCAGTTAGCTTCCTTCATGT; Reg3g 5′ CCTTCC
TCTTCCTCAGGCAAT, 3′ TAATTCTCTCTCCACTTCAGAAATCCT; IL-17A 5′
ACTACCTCAACCGTTCCACG, 3′ AGAATTCATGTGGTGGTCCAG.
2.3. Obesity models
Except where otherwise indicated, 6–7 week-old male mice were
placed on a high-fat diet (HFD; 60% of kcal from fat, carbohydrate 20%
kcal, protein 20% kcal; Research Diets #D12492i), a chow diet (Chow;
fat 13.5% kcal, carbohydrate 59% kcal, protein 27.5% kcal; Lab Diet
#5010), a semi-purified low fat diet (LFD; fat 10% kcal, carbohydrate
70%kcal, protein 20% kcal; Research Diet #D12450Bi), or autoclavable
chow from Jackson Labs present in the shipping container, in which
mice were received (Jax Chow; fat 16% kcal, carbohydrate 61.7%kcal,
protein 22.2%kcal; Lab Diet#5K67). Animals were weighed weekly.
Fresh food was provided on a weekly basis and food consumption was
quantified weekly.
Quantification of fasting glucose was carried out as follows. Mice were
fasted overnight (12 h) and the glucose level in a single drop of blood
was quantified using the FreeStyle flash blood glucose monitoring
system (Abbot Diabetes Care Inc.). Insulin tolerance testing was carried
out as follows. Mice were fasted during the day (8 h) and challenged via
intraperitoneal injection (10 μL/g of body weight) with 1.5 U/kg Novolin
R insulin (Novo Nordisk Inc.). Immediately following injection, and
kinetically thereafter, one drop of blood was collected and analyzed for
glucose levels as above. Glucose tolerance testing was carried out asISM 2 (2013) 171–183 & 2013 Elsevier GmbH. All rights reserved. www.molecularmetabolism.com
follows. Mice were fasted overnight and challenged via intraperitoneal
injection (10 μL/g of body weight) with 10% dextrose dissolved in
normal saline (Sigma). Glucose levels were then analyzed as in insulin
tolerance testing. Hemoglobin A1C was quantified using A1CNowþ
(Bayer) according to the manufacturer's instructions [40].2.4. Colonization
Broadly speaking, mice were colonized as indicated and colonization
was assessed 2 weeks later on the day of (but prior to) the initiation of
HFD-challenge. In particular, 4–8 week-old male C57BL/6 mice were
colonized via oral gavage with a slurry of fecal material dissolved in PBS.
The slurry contained either: (1) an isolate of SFB obtained (as described
below) from the terminal ilea of MPF health status C57BL/6NTac mice;
or (2) the fecal material of a conventionally raised mouse, as indicated.
Oral gavage of autologous fecal material served as a control. Experi-
ments aimed at transferring a single bacterial species whether from SFB
monocolonized fecal material or a pure culture of Lactobacillus murinus
included a 1:1 mixture of pooled autologous fecal material to control for
effects of gavage with only a single bacterial species versus a complex
mixture of bacterial species, with one exception: SFB-enriched micro-
biota isolated from the terminal ilea of mice from Taconic Farms was
transferred by itself, without the addition of autologous fecal material.
Colonization was assessed by quantitation of SFB or L. murinus levels in
fecal pellets obtained 2 weeks later on the day of (but prior to) the
initiation of HFD challenge. In the experiments depicted in Figures 4G,
7A and 8D, WT C57BL/6 breeders from Jackson labs were colonized as
indicated. The colonization status of their 4–6 week-old offspring was
verified, and the offspring were subsequently subjected to HFD-
challenge for 12 weeks. For the cohousing experiment in Figure 8A,
4 week-old C57BL/6 males from Jackson Labs or Taconic Farms were
housed with a single 4 week-old C57BL/6 female from the other vendor
for a period of 2 weeks. After 2 weeks, the females were removed and
the males were subjected to HFD challenge. For the experiment in
shown in Figure 9, 6–8 week-old germ-free C57BL/6J males (from the
National Gnotobiotic Rodent Research Center; originally derived from
mice obtained from Jackson Labs) were colonized as above with fecal
material from conventionally raised mice. SFB-monoassociated mice
were maintained at the UNC National Gnotobiotic Rodent Resource
Center as a source SFB. SFB containing stools used to colonize these
mice were provided by Drs. Y. Umesaki and A. Imaoka, Yakult Center
Laboratories, who isolated SFB by limiting dilution [41].2.5. Enrichment of SFB from the terminal ilea of conventionally raised
mice
SFB was enriched from conventionally-raised mice using a method
similar to the procedure described for the isolation of SFB from
gnotobiotic mice colonized with a mixture of clostridial species and
SFB [42]. Briefly, 6 cm sections of terminal ileum (starting 1 cm
proximal to the ileo-cecal junction) were isolated under sterile conditions
in a laminar flow hood and homogenized in a bead beater. This
homogenate was then shaken in sterile-filtered ethanol, washed and left
in culture medium (Lactobacilli MRS Broth, Difco) under aerobic
conditions at 37 1C and 5% CO2 overnight. The next day, it was used
to colonize 4 week-old C57BL/6 males from Jackson Labs. C57BL/6
males from Jackson Labs gavaged with their own fecal material were
controls. Specificity of colonization (SFB-positive, L. murinus-negative)
was confirmed 2 weeks later via qPCR analysis of fecal pellets (pooled
by cage).MOLECULAR METABOLISM 2 (2013) 171–183 & 2013 Elsevier GmbH. All rights reserved. www.mo2.6. Energy expenditure analysis
Mice were received from the vendors, individually housed in standard
housing and fed chow for 1 week. Following this, they were transferred
to PhenoMaster/LabMaster cage system (TSE Systems, Inc). Food and
water intake, locomotor activity, VO2 and VCO2 were measured every
10 min for 210 h. Subsequently, the mice were transferred to standard
housing and their food intake in response to challenge with recombinant
human leptin (1 mg/kg of total body mass) was assessed. Terminal body
composition (EchoMRI) and bacterial colonization were assessed.
Respiratory exchange rate was calculated from VO2 and VCO2.
2.7. Statistical analysis
Data were analyzed by one-way ANOVA, followed by Tukey's correction
for multiple comparisons or unpaired Student's t-test. For longitudinal
data over the course of HFD-feeding, repeated measures ANOVA or
paired Student's t-test was used, as appropriate.3. RESULTS
3.1. C57BL/6 mice from Jackson Labs are protected from obesity and
many of its adverse sequelae, compared to C57BL/6 mice from Taconic
Farms
We tested the hypothesis that the differential rate of development of DIO
exhibited by C57BL/6 mice from two separate commercial vendors,
Jackson Labs and Taconic Farms, was due to differences in their gut
microbiota. Mice from Taconic Farms are colonized with SFB and
L. murinus, whereas those from Jackson Labs are not [25]. Confirming
previous reports [30–33], when subjected to the stress of HFD feeding,
mice from Jackson Labs exhibited resistance to the development of
obesity, compared with mice from Taconic Farms (Figure 1A). This was
not a subtle phenotype. Significant differences in body weight were
observed within the first few weeks of HFD feeding (Figure S1A and
S1B). Notably, significant differences in food intake were not observed
(Figure S1C and S1D). In this model, the size of the epididymal white
adipose tissue depot reaches an apex that coincides with a metabolic
crisis marked by white adipose tissue inflammation, systemic insulin
resistance, epididymal white adipocyte death (associated with contrac-
tion of this depot), elevation in serum triglycerides, hepatomegaly and
hepatic steatosis [43]. As this occurs, epididymal white adipose tissue
lipids undergo redistribution: to the blood (with increased serum
triglyceride concentrations), and to the liver (leading to steatosis and
hepatomegaly) [43]. This lipid redistribution is marked by negative
correlation between liver and epididymal white adipose tissue weight [43].
While inguinal white adipose tissue weight parallels body weight, and
serves as a proxy for adiposity in this model (Figure 1B), integration of
epididymal white adipose tissue weight and liver weight thus serves as a
proxy for relative metabolic status and overall progression in the model
[43]. Of note, in parallel with the increased obesity observed in C57BL/6
mice from Taconic Farms, such mice exhibited decreases in both
epididymal white adipose tissue weight and increased liver weight,
indicative of poor metabolic outcome (Figure 1C and D).
To quantify glucose (dys)metabolism in these mice, formal metabolic
testing was carried out. Insulin tolerance testing revealed increased
insulin resistance, commensurate with greater obesity, in mice from
Taconic Farms (Figure 2A, B). Curiously, no significant differences
were observed in glucose tolerance or fasting hyperglycemia between
mice from the two vendors (Figure 2C–E). Given the tightly coupled
relationship between obesity and glucose dysmetabolism observed in
HFD-fed C57BL/6 mice [44], the mice from Jackson Labs would havelecularmetabolism.com 173
Figure 2: Insulin resistance tracks with obesity in mice from different vendors. C57BL/6 mice from the indicated vendors were place on HFD or chow diet, as indicated. (A, B) Insulin tolerance test
(ITT) after 14 weeks of HFD feeding: (A) Kinetic analysis; (B) Area under the curve (AUC) analysis. (C, D) Glucose tolerance Test (GTT) after 11 weeks of HFD feeding: (C) Kinetic analysis; (D) AUC
analysis. (E) Fasting blood glucose after 9 weeks of HFD feeding. Data represent meansþSE of an N¼4–6 mice/condition. (B, D, E), *Po0.01, unpaired Student’s t-test. Data are from a single
experiment.
Figure 1: Vendor source alters HFD-induced obesity in C57BL/6 mice. C57BL/6 mice from the indicated vendors were placed on HFD or chow diet for 16 weeks.
(A) Body weight. (B) Inguinal white adipose tissue (iWAT) weight. (C) Perigonadal white adipose tissue (eWAT) weight. (D) Liver weight. Data represent meansþSE of an N¼8–9 mice/condition.
(A) *Po0.01, one-way repeated measures ANOVA with Tukey’s correction. (B–D) *Po0.01, one-way ANOVA with Tukey’s correction. One experiment, representative of 6 independent
experiments. Jax, Jackson Laboratories; Tac, Taconic Farms.
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been expected to exhibit protection from glucose intolerance and
fasting hyperglycemia on the basis of their relative leanness.
Importantly, however, C57BL/6 mice from Jackson Labs carry a
loss-of-function mutant allele (NntB6J) of the gene encoding the
nicotinamide nucleotide transhydrogenase (Nnt), whereas C57BL/6
mice from Taconic Farms carry the wild type allele (NntWT) [45]. NNT
activity regulates glucose-stimulated insulin release from the pancreas
[46]. Thus, Nnt mutants would be expected to exhibit increased
glucose intolerance and fasting hyperglycemia relative to equivalently
obese controls. However, as noted above, the C57BL/6 mice from
Jackson Labs were leaner than their C57BL/6 counterparts from
Taconic Farms. In this instance, it appears that the competing effects
of DIO and the Nnt mutation on fasting hyperglycemia and glucose
intolerance cancel each other out.3.2. Known genetic differences between C57BL/6 substrains do not
explain divergence in obesity phenotype
Given the variant Nnt alleles in these C57BL/6 substrains, it was
important to rule out a contributory role for Nnt in the divergent response
of these substrains to HFD challenge. Thus, the response to HFD
challenge of both NntWT mice (C57BL/6NJ) and NntB6J mice (C57BL/6J)
from Jackson Labs was compared to that of NntWT mice (C57BL/6NTac)
from Taconic Farms. In agreement with a prior report comparing DIO in
NntWT and NntB6J mice with the same model [47], we found that, relative
to NntB6J mice raised in the same facility at Jackson Labs, NntWT mice
were protected from the development of obesity (Figure 3). Thus, Nnt
genotype, by itself, is not responsible for the increased obesity observedFigure 3: Mutant nicotinamide nucleotide transhydrogenase (NntB6J) is not responsible for protec
and Taconic Farms (Tac/N, C57BL/6NTac), and NntB6J mutant C57BL/6 mice from Jackson Labs (
white adipose tissue (iWAT) weight. (C) Perigonadal white adipose tissue (eWAT) weight. (D) Live
repeated measures ANOVA with Tukey’s correction. (B–D) *Po0.01, one-way ANOVA with Tuk
MOLECULAR METABOLISM 2 (2013) 171–183 & 2013 Elsevier GmbH. All rights reserved. www.moin C57BL/6 mice from Taconic Farms, though it appears to exacerbate
HFD-induced glucose intolerance (Figure 2).3.3. SFB is not obesogenic
Having ruled out the Nnt mutation as an explanation for these divergent
obesity phenotypes, we addressed our primary hypothesis: that differences
in specific members of the gut microbiota were responsible. In light of the
established contribution of immune regulation in microbiota-mediated
obesity [16,17] and the specific induction of a number of immunometabolic
genes by SFB [25], we first focused our attention on SFB, a commensal
found in C57BL/6 mice from Taconic Farms but absent in C57BL/6 mice
from Jackson Labs [25]. We took three complementary approaches to
defining whether differential colonization with SFB underlay these differ-
ential responses to HFD stress. First, we isolated SFB-enriched microbiota
from the ileum of C57BL/6 mice from Taconic Farms, and colonized C57BL/
6 mice from Jackson Labs (by oral gavage) with this isolate after weaning.
Recipient mice did not exhibit increased weight gain in comparison to
mock-colonized C57BL/6 mice (Figure 4A–C). Second, we found that, while
C57BL/6 mice from Taconic Farms of the “Murine Pathogen Free™” (MPF)
health status were colonized with SFB and L. murinus, C57BL/6 mice from
Taconic Farms of the “Restricted Flora™” (RF) health status were only
colonized with L. murinus (Figure S2). Thus, we compared C57BL/6 RF
mice that were colonized by oral gavage (again, after weaning) with MPF
fecal material (SFB positive and L. murinus positive), autologous RF fecal
material (SFB negative and L. murinus positive) or Jackson fecal material
(SFB negative and L. murinus negative). As shown in Figure 4D–F, no
differences in the development of obesity were observed in these mice.tion from obesity. NntWT C57BL/6 mice obtained from both Jackson Labs (Jax/N, C57BL/6NJ)
Jax/J, C57BL/6J), were placed on HFD or chow diet for 16 weeks. (A) Body weight. (B) Inguinal
r weight. Data represent meansþSE of an N¼3–6 mice/condition. (A) *Po0.01, one-way
ey’s correction. Data are from a single experiment.
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Figure 4: SFB is not responsible for accelerated obesity in Taconic mice. (A–C) Colonization with SFB isolated from Taconic mice: C57BL/6 mice from Jackson Labs were colonized via oral
gavage with either SFB isolated from C57BL/6 mice from Taconic Farms, or mock-colonized, and placed on HFD or chow diet for 12 weeks. (A) Body weight. (B, C) Fecal bacterial levels (pooled
by cage), 6 week-old (prior to diet challenge): (B) SFB. (C) L. murinus. (D–F) Colonization of C57BL/6NTac mice with SFB: SFB-negative C57BL/6NTac RF health status mice were colonized via
oral gavage with fecal material either from C57BL/6NTac MPF health status mice or C57BL/6J mice from Jackson Labs and placed on HFD or chow diet for 12 weeks. (D) Body weight. (E, F)
Fecal bacterial levels (pooled by cage), 6 week-old: (E) SFB. (F) L. murinus. (G–H) Vertical colonization of C57BL/6 mice with SFB: C57BL/6 mice from Jackson Labs were colonized with
autologous SFB-negative fecal material, alone or in combination with SFB-positive fecal material from mice monocolonized with SFB. Progeny were place on HFD for 12 weeks. (G) Body weight. (H,
I) Fecal bacterial levels (pooled by cage), 4 week-old: (H) SFB. (I) L. murinus. Data represent meansþSE. A–C: N¼6–9 mice/condition; D–F: N¼4–9 mice/condition; G–I: N¼8–11 mice/
condition. (A, D, G) *Po0.01, one-way repeated measures ANOVA with Tukey’s correction. Data are from a single experiment.
Original articleFinally, since adoptive transfer via oral gavage shortly after weaning may
not be entirely physiological, we sought to more closely mimic natural
colonization with SFB. To do this, C57BL/6 breeders from Jackson Labs
were colonized with autologous fecal material, alone or in combination with
fecal material from an SFB mono-associated mouse. Again, SFB-colonized
mice did not exhibit increased obesity, compared with SFB-negative mice
(Figure 4G–I).
We also quantified SFB colonization density in C57BL/6 mice from
Taconic Farms (Jackson Labs as a negative control) at the time of
harvest in diet challenge studies. SFB colonization density is known to
decline after weaning, with the induction of mucosal immune responses
[48]. Of note, HFD feeding led to significantly greater suppression of
terminal ileal SFB levels than chow feeding (Figure 5A and B).
Importantly, the HFD employed for these studies is a semi-purified
elemental diet, as opposed to the natural ingredient chow diet control.
Prior reports indicate that mice fed semi-purified diets are resistant to
colonization with SFB [49]. We also found that C57BL/6 mice from
Jackson Labs fed a semi-purified low-fat control diet (LFD) were
resistant to colonization with SFB (data not shown). This effect was also176 MOLECULAR METABOLevident in mice with established SFB colonization, as lower fecal SFB
levels were also observed in C57BL/6 mice from Taconic Farms within a
week of switching to this diet (Figure 5C). As the vitamin A levels
present in the natural ingredient chow diets fed at the Jackson Labs and
Taconic Farms facilities vary, and since vitamin A levels are known to
influence SFB carriage [50], we determined whether feeding the chow
diet used at Jackson Labs to C57BL/6 mice from Taconic farms also
altered SFB levels. As shown in Figure 5C, feeding Jackson Labs chow
led to rapid suppression of fecal SFB levels. Taken together, these data
indicate that SFB is exquisitely sensitive to dietary composition, and
suggest that dietary differences may play a role in divergent SFB
colonization in mice from Jackson Labs and Taconic Farms.
This observation provided another experimental approach to address the
contribution of SFB to the development of obesity–LFD challenge.
Dietary challenge of C57BL/6 mice from the 2 vendors with the
obesogenic LFD (despite the “low fat” designation, the diet is markedly
more calorie dense than standard chow) replicated the differential
weight gain (C57BL/6 mice from Taconic Farms4C57BL/6 mice from
Jackson Labs) with HFD challenge (Figure S3). The fact that thisISM 2 (2013) 171–183 & 2013 Elsevier GmbH. All rights reserved. www.molecularmetabolism.com
Figure 5: SFB colonization is acutely sensitive to dietary composition, whereas L. murinus is not. (A–C) SFB levels. (A) Terminal ileum after 1 week on the indicated diet. (B) Terminal ileum after 16
weeks on diet. (C) Fecal pellet, after 4 days on diet. (D) Il17a mRNA expression in terminal ileum after 2 weeks on the indicated diet. (E, F) L. murinus levels: (E) Terminal ileum after 1 week on diet;
(F) Terminal ileum, after 16 weeks on diet. Data represent meansþSE. (A, E) N¼4–8 mice/condition; (B, F) N¼4–10 mice/condition; (C) N¼2–3 mice/condition; (D) N¼6 mice/condition.
Data (A) and (E) are from the same experiment. Data in (B) and (F) are from the same experiment. Otherwise, each panel represents a separate experiment performed once. (A–C, E, F) *Po0.01,
one-way ANOVA with Tukey’s correction. (D) *Po0.05, unpaired Student’s t-test.increased obesity occurred in the absence of detectable SFB lends
further support to the conclusion that SFB is not responsible for
differential weight gain between mice from these vendors.
This decline in SFB levels was also associated with modulation of
immune responses. HFD-fed C57BL/6 mice from Taconic Farms
displayed a relative defect in the expression of anti-microbial effectors
[25,51] in the terminal ileum that are acutely induced following
colonization of naïve mice with SFB [25] (Figure S4). Decreased
expression of these effectors is consistent with a parallel decline in
SFB levels during HFD-feeding. Similarly, alterations in the SFB-
stimulated immune response were observed in LFD-fed C57BL/6 mice
from Taconic Farms, as they displayed decreased IL-17A (Figure 5D)
and IL-17F (data not shown) expression in their terminal ilea relative to
chow-fed C57BL/6 mice from Taconic Farms.
3.4. L. murinus is not obesogenic
While gut SFB levels rapidly decline with HFD challenge, levels of L.
murinus do not. In fact, L. murinus levels in the terminal ileum appear to
increase during the course of both HFD and chow feeding (Figure 5E and
F). L. murinus is a member of the model microbiota, altered Schaedler
flora that is used as a basal inoculum in all re-derived strains at Taconic
Farms [25]. While L. murinus is considered to be typical commensal
[37], it is reported to translocate to mesenteric lymph nodes at a higher-
than-expected rate for a commensal [34], something with obvious
potential immune stimulatory properties. We thus defined the potential
contribution of L. murinus to DIO by colonizing C57BL/6 breeders from
Jackson Labs with autologous fecal material, alone or in combination
with a pure culture of L. murinus, and then challenged their progeny
with HFD feeding. No significant differences in the development of
obesity between L. murinus positive and negative mice were observed
(Figure 6A–C). Additionally, C57BL/6 mice from Jackson Labs wereMOLECULAR METABOLISM 2 (2013) 171–183 & 2013 Elsevier GmbH. All rights reserved. www.mocolonized with either autologous fecal material or with fecal material
from C57BL/6 RF mice (SFB negative and L. murinus positive). Again, no
significant differences in the development of obesity were observed
(Figure 6D–F). Taken together, these data indicate that L. murinus is not
responsible for the divergent propensity to develop obesity in C57BL/6
mice from Jackson Labs and Taconic Farms.
3.5. Taconic Farms microbiota is not obesogenic
The above experiments eliminated SFB and L. murinus, previously
reported to be the gut microbiota components that varied most greatly
between the mice from these vendors [25,52], as playing a causal role
in the divergent responses of these C57BL/6 substrains to HFD stress.
They did not, however, address the potential contribution of the broader
microbiota of these mice. We thus addressed the role of the entire
horizontally transmissible members of the microbiota using similar
approaches. First, we employed reciprocal co-housing of C57BL/6 mice
from Taconic Farms and Jackson Labs. As shown in Figure 7A–C, such
co-housing failed to eliminate differences in the obesity response.
Second, in the same experiment displayed in Figure 4G, we defined the
contribution of the horizontally transmissible members of the Taconic
microbiota to DIO by colonizing C57BL/6 breeders from Jackson Labs
with autologous fecal material or fecal material from MPF health status
C57BL/6 mice, and then challenging their progeny with HFD-feeding.
No significant difference in the development of obesity was found
between the progeny of these mice (Figure 7D–F). Taken together, these
data indicate that the portion of the gut microbiota that is horizontally
transmissible to conventionally raised mice is not responsible for the
divergent obesity phenotypes observed in these mice.
To investigate the possibility that pre-existing microbial colonization
might inhibit horizontal transmission of a critical component of the
microbiota of mice from Taconic Farms responsible for divergent weightlecularmetabolism.com 177
Figure 6: L. murinus is not responsible for accelerated obesity. (A–C) Colonization of C57BL/6 mice from birth: C57BL/6 mice from Jackson Labs were colonized with autologous fecal material
alone (Jax) or in combination with pure culture of L. murinus (Lm). Progeny were placed on HFD or chow diet for 12 weeks. (A) Body weight. (B, C) Fecal bacterial levels (pooled by cage), 4 week-
old (B) SFB. (C) L. murinus. (D–F) Colonization of C57BL/6 mice with L. murinus from Taconic Farms: C57BL/6 mice from Jackson Labs were colonized with autologous SFB-negative fecal
material (Jax) or Taconic “Restricted Flora” (RF) fecal material. (C) Body weight. (E, F) Fecal bacterial levels (pooled by cage), 6 week-old (E) SFB. (F) L. murinus. Data represent meansþSE. (A–C)
N¼9–10 mice/condition, from one experiment, representative of two independent experiments. (D–F) N¼4–9 mice/condition, from a separate experiment performed once. (A, D) *Po0.01,
one-way repeated measures ANOVA with Tukey’s correction.
Original articlephenotypes, gnotobiotic C57BL/6J mice were colonized with either
Taconic or Jackson microbiota and subjected to HFD-challenge
(Figure 8). Of note, such mice did not exhibit significant differences in
body weight (Figure 8A) even though they were successfully colonized
(or not) with Taconic microbiota as indicated by L. murinus and SFB
levels (Figure 8B, C). Thus, divergent microbiota do not account for the
divergent development of obesity of C57BL/6 mice from these two
vendors.
3.6. Constitutive differences in locomotor activity correlate with the
divergent development of obesity
To further dissect the divergent obesity phenotypes in C57BL/6 mice from
Taconic Farms and Jackson Labs, we housed these mice in metabolic
cages for 1 week and observed a significant increase in body weight of
HFD-fed C57BL/6 mice from Taconic Farms relative to those from Jackson
Labs (Figure S5). In parallel, we observed a trend towards increased
percentage of body fat mass, consistent with obesity (Figure S5). Only
modest differences in food intake (both total and body-weight adjusted),
energy expenditure (whether mean or cumulative, both total and metabolic
mass adjusted), respiratory quotient or leptin-driven food intake were
observed (Figures S6–S8, and data not shown). However, C57BL/6 mice
from Taconic Farms and Jackson Labs displayed significant differences in
their fine, ambulatory and total locomotor activity, with the (leaner) C57BL/6
mice from Jackson Labs exhibiting greater activity (Figures 9 and S9).
Increased locomotor activity might seem counterintuitive in the face of no178 MOLECULAR METABOLquantifiable differences in energy expenditure in these metabolic cages.
However, despite the modest contribution of locomotor activity to total
energy expenditure [53], the cumulative effects of increases in locomotor
activity can translate into sizable differences in weight gain over time.
Previous work, seeking to dissect the relative contribution of basal
metabolism and locomotor activity to weight gain with western diet
challenge found that a 2-fold increase in locomotor activity could account
for an approximately 0.5 g decrement in body weight gain per week, even
though differences in total energy expenditure were undetectable during this
period in similar metabolic cages [53]. Thus, the observed difference in
locomotor activity likely accounts for most of the divergence in the
development of DIO in C57BL/6 mice from Jackson Labs and mice from
Taconic Farms.4. DISCUSSION
Taken together, our data indicate that variations in the gut microbiota
between C57BL/6 mice from Jackson Labs and Taconic Farms are not
responsible for their divergent development of diet-induced obesity.
More broadly, our data suggest that differences in the gut microbiota do
not materially contribute to the development of DIO in conventionally
raised wild type mice. Of course, systematic investigation of additional
strains of wild type mice raised under a greater diversity ofISM 2 (2013) 171–183 & 2013 Elsevier GmbH. All rights reserved. www.molecularmetabolism.com
Figure 7: Horizontally transmissible gut microbiota in mice from Taconic Farms is not responsible for accelerated obesity. (A–C) Reciprocal Co-Housing: C57BL/6 males from the indicated vendor
were housed with females from the other vendor for 2 weeks (Taconic males with Jackson females, and vice versa) and placed on HFD or chow for 16 weeks. (A) Body weight. (B, C) Fecal
bacterial levels, 6 week-old (B) SFB. (C) L. murinus. (D–F) Colonization of C57BL/6 mice from Jackson Labs with Taconic fecal material from birth: C57BL/6 mice from Jackson Labs were
colonized with either autologous SFB-negative fecal material or exogenous fecal material of mice from Taconic Farms. Progeny were placed on HFD for 12 weeks. (D) Body weight. (E, F) Fecal
bacterial levels (pooled by cage), 4 week-old: (E) SFB. (F) L. murinus. Data represent meansþSE. (A–C) N¼7–8 mice/condition from a single experiment. (D–F) N¼10–11 mice/condition from
a single experiment. (A, D) *Po0.01, one-way repeated measures ANOVA with Tukey’s correction.environmental conditions would be required to draw the more general
conclusion.
These data mirror that from unpublished studies in the lab aimed at
defining the contribution of SFB to the development of non-alcoholic
fatty liver disease (NAFLD) In these studies, the contributions of SFB
were analyzed using three approaches: (1) colonization of C57BL/6 mice
from Jackson Labs via oral gavage with SFB-monocolonized fecal
material; (2) vancomycin-mediated depletion of SFB in C57BL/6 mice
from Taconic Farms; and (3) colonization of Leprdb/db mice from Jackson
Labs via oral gavage with SFB-monocolonized fecal material. While the
focus of this work was on NAFLD, obesity was also quantified. We found
that neither colonization with, nor depletion of, SFB altered the
development of obesity in C57BL/6 mice; whereas colonization of
Leprdb/db mice with SFB led to a moderate (10%) decrease in body
weight (unpublished). The experimental approaches used carry caveats,
however. On the one hand, SFB colonization of C57BL/6 mice from
Jackson Labs using fecal material from SFB mono-associated mice
resulted in lower levels of fecal SFB than did colonization with fecal
material from Taconic Farms. This suggests that SFB growing in the
competitive environment of conventionally raised mice from Taconic
Farms have a competitive advantage compared with SFB repetitively
passaged in the competition-free environment of mono-associated mice.
On the other hand, selective depletion of SFB using vancomycin
dramatically alters intestinal microbial ecology [54] and could confound
results if other vancomycin-susceptible microbes made a negativeMOLECULAR METABOLISM 2 (2013) 171–183 & 2013 Elsevier GmbH. All rights reserved. www.mocontribution to the development of DIO. The decreased body weight in
Leprdb/db mice colonized with SFB relative to their mock-colonized
counterparts suggests that colonization with SFB might actually protect
from obesity under some circumstances. Such protection might be
explained by SFB-mediated induction of IL-17 family cytokines, which
have described roles in reduction of adipogenesis and weight gain in DIO
models [55]. Consistent with this, we occasionally observed statistically
significant but biologically modest protection from obesity in SFB-
positive mice, in refutation of the hypothesis that SFB is obesogenic, a
hypothesis suggested by the divergent course of DIO in C57BL/6 mice
from Taconic Farms and Jackson Labs (Figure 4A and G). Together with
the data presented here, these parallel data definitively exclude a role
for SFB in promoting obesity.
Similarly, these parallel unpublished studies shed additional (negative)
light on the potential contribution of L. murinus to obesity. As noted
above, vancomycin-treated C57BL/6 mice from Taconic Farms did not
diverge in their development of obesity. Most Lactobacillus species are
intrinsically resistant to vancomycin [56] and L. murinus is no exception.
In fact, L. murinus levels expand significantly during vancomycin
treatment, likely at the expense of other bacterial species (data not
shown). This observation further supports the conclusion that L. murinus
is not responsible for the divergence in DIO between C57BL/6 mice from
Taconic Farms and Jackson Labs.
These experiments further address the potential contribution of microbes
that are not horizontally transmissible to conventional mice that is, thelecularmetabolism.com 179
Figure 8: Taconic Farms gut microbiota is not responsible for accelerated obesity in gnotobiotic mice. (A–F) 6–8 week-old germ-free C57BL/6J males were colonized with fecal material from
mice obtained from the indicated vendor, fed chow for 2 weeks, and then switched to HFD for 12 weeks. (A) Body weight. (B, C) Fecal bacterial levels after 2 weeks on chow diet. (B) SFB. (C) L.
murinus. (D) Inguinal white adipose tissue (iWAT) weight. (E) Perigonadal white adipose tissue (eWAT) weight. (F) Liver weight. Data represent meansþSE. (A–F) N¼6–8 mice/condition from a
single experiment. (A) *Po0.01, paired Student’s t-test. (D–F) *Po0.01, unpaired Student’s t-test.
Figure 9: Mice from Taconic exhibit increased locomotor activity regardless of diet. C57BL/6 mice from the indicated vendor were individually housed in metabolic cages from TSE Systems. After
2 days of chow feeding, HFD-challenge was initiated. (A) Cumulative total locomotor activity. (B) Average total locomotor activity. (C) Diurnal average total locomotor activity. Data represent
meansþSE of an N¼4–5 mice/condition. (B, C) *Po0.01, one-way ANOVA with Tukey’s correction. Data are from a single experiment.
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constituents of the microbiota that are not transferrable into mice with a
pre-existing microbial community structure. To formally address this
possibility, we performed the relevant microbiota transfers into gnotobiotic
recipients. Taken together, our data indicate that divergent microbiota are
not responsible for the divergent DIO response between C57BL/6
substrains. Of note, a recent study has implicated an SFB-enriched
microbiota as protective in similar models of DIO in the context of IL-22
pathway deficiency [57]. Our data indicate that either SFB is likely not
responsible for modulating the development of obesity in such mice or that
the contribution of such microbiota to obesity is less pronounced in the
context of a fully functional immune response. Whether our data have
broader implications on the role microbiome-mediated modulation of
obesity development remains to be determined.
Regardless of the role of the gut microbiota, our studies highlight the need for
critical attention to the selection of control groups in studies employing DIO
models. Substrains of C57BL/6 mice commonly used to model human
obesity differ in their response to HFD feeding. This difference is in addition to,
and apparently independent of, a previously-described genetic mutation that
varies between substrains of C57BL/6.
We have yet to identify the underlying causal mechanism(s) responsible for
these phenotypic differences. We have, however, identified a potentially
useful proxy (and likely intermediate mechanism): locomotor activity, which
may have utility in defining underlying cause(s). By itself, altered locomotor
activity is consistent with a role for microbiota, other environmental factors,
or genetic effects. On the one hand, a previous retrospective analysis of
behavioral testing on thousands of mice over several years found that mice
of the C57BL/6J substrain exhibited increased spontaneous locomotor
activity relative to C57BL/6N mice [58]. The scale of analysis and the varied
sources of mice studied [58] suggest that this difference in locomotor
activity has a genetic basis. On the other hand, studies of locomotion in
germ-free and conventionally raised mice suggest possibility role for
environmental factors, as germ-free mice exhibit increased locomotion
relative to conventionally raised or conventionalized (that is, previously
germ-free colonized with conventional microbiota) mice [12,59]. Regardless
of the ultimate cause of differences in locomotion, the proximal cause of the
divergent development of obesity is likely locomotion, as differences in
locomotion acutely contribute to weight gain on a time-scale consistent with
the rapid increase in body weight that we have observed [53].
As for underlying environmental mechanisms, plausible candidates
abound. First, the diets used by these vendors differ in their vitamin
A concentration. While the differences are relatively modest, early life
exposure to this vitamin and its metabolites, which alters thermogenic
adipose tissue development [60], could alter the subsequent response to
HFD-challenge. Second, while the mean reported temperatures main-
tained by these vendors are similar, the range of acceptable tempera-
tures at the Jackson Labs facilities is wider than at the facilities at
Taconic Farms. Given the profound effects of even moderate cold-stress
on non-shivering thermogenesis and the development of obesity [61],
such differences might explain subsequent differences in locomotor
activity and in the development of DIO. Third, it remains possible that an
as-yet unknown genetic difference between the C57BL/6 substrains is
responsible [62].
The current studies provide an experimental framework to address a key
question in the study of the effects of the microbiota on obesity: Does the
microbiome exert effects on obesity through the action of specific
individual species? As part of this, we have developed a number of
experimental procedures (as well as instructive experimental dead ends)
that may prove useful in dissection of the (patho)physiologic conse-
quences of gut microbiota variation more generally. It should be noted,
however, that an alternative question might provide an experimentalMOLECULAR METABOLISM 2 (2013) 171–183 & 2013 Elsevier GmbH. All rights reserved. www.mopathway with more traction: Does the microbiome exert effects on obesity
through expression of species-independent metagenomic pathways [15]?ACKNOWLEDGMENTS
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